Hexaminolevulinate Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg , 85 mg

Reference Brands: Cysview (USA), Hexvix (EU)

Category: Medical Aid

Hexaminolevulinate Hydrochloride is available in Injection and strengths such as 100 mg , 85 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Hexaminolevulinate Hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Hexaminolevulinate Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Hexaminolevulinate hydrochloride is the hydrochloride salt form of hexaminolevulinate, a hexyl ester of the heme precursor 5-aminolevulinic acid (ALA) with photosensitizing properties. Marketed under the brand name Cysview in the USA and Hexvix in the EU/UK, it is an imaging agent used in blue-light cystoscopy to enhance detection of non-muscle invasive bladder cancer (NMIBC), including papillary tumors and carcinoma in situ (CIS).

Hexaminolevulinate functions as a precursor to photoactive porphyrins (PAPs), particularly protoporphyrin IX (PpIX), which selectively accumulate in rapidly proliferating tumor cells. Upon exposure to blue light, these porphyrins are activated and emit red fluorescence, allowing clinicians to visualize malignant tissue that may be difficult to detect under standard white-light cystoscopy.

Administered via intravesical instillation, hexaminolevulinate provides enhanced tumor detection, helping guide biopsy and improve diagnostic accuracy. Its selective uptake in malignant urothelial cells ensures minimal background fluorescence in healthy tissue, making it a valuable tool in the early identification and management of bladder cancer. Hexaminolevulinate should be used under medical supervision with appropriate procedural protocols for optimal outcomes.